No­var­tis’ CD­MO arm eyes growth, scope to wel­come com­peti­tors’ clients 

As No­var­tis ex­pands its CD­MO busi­ness, it says it is al­so “in dis­cus­sions” to fur­ther boost its client list amid cur­rent “dis­rup­tive mo­ments” in the man­u­fac­tur­ing in­dus­try.

Once the phar­ma gi­ant sta­bi­lizes man­u­fac­tur­ing for its ra­dio­phar­ma­ceu­ti­cals like Plu­vic­to, it will al­so look in­to be­com­ing a third-par­ty pro­duc­er for oth­er ra­dio­phar­ma com­pa­nies.

“It’s very dy­nam­ic … It’s an ex­cit­ing time with the CMO mar­ket,” Christoph Buer­ki, No­var­tis’ CFO of op­er­a­tions and con­tract man­u­fac­tur­ing or­ga­ni­za­tion head, told End­points News in an in­ter­view.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER